Fact CheckerSign in

NCT07163039Not yet recruiting

The Effect of Dual Task Training on Cognitive in Alzheimer's Disease

Source: ClinicalTrials.gov · Last updated 9 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This randomized controlled clinical trial aims to evaluate the effectiveness of dual-task training on cognitive functions in patients with Alzheimer's disease. Participants will be randomly assigned to either a dual-task training group or a conventional exercise group. The intervention will last 8 weeks, with three supervised sessions per week. Cognitive performance, mobility, balance, and quality of life will be assessed before and after the intervention.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
21 Aug 2025
Start date
Sept 2025
Primary completion date
Oct 2025
Lead sponsor
Fenerbahce University
NCT number
NCT07163039

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From Sept 2025 to the primary completion date, Oct 2025
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Individuals with unstable cognitive status due to recent medication changes

Other illness

  • Diagnosis of advanced-stage Alzheimer's disease (MoCA \< 10)
  • Presence of additional neurological disorders affecting the motor system (e.g. Parkinson's disease, stroke, multiple sclerosis)
  • Severe hearing or vision impairment (inability to respond to visual or auditory stimuli)
  • History of psychiatric disorders (e.g., major depression, schizophrenia)
  • Orthopedic or cardiopulmonary conditions that would prevent participation in dual-task training

Other

  • Participation in another cognitive or physical rehabilitation program within the last 3 months

Who the study is looking for

  • Age ≥ 60 years
  • Diagnosed with mild-stage Alzheimer's disease (According to DSM-5 or NINCDS-ADRDA criteria)
  • MoCA score between 10-25 (Indicating sufficient cognitive capacity for dual-task training)
  • Ability to walk independently or with minimal assistance
  • Adequate hearing and vision to enable communication
  • Physical and mental capacity to participate in the dual-task training protocol
  • Provision of written informed consent (signed informed consent form)

Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.